Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer

Study Overview
=================
Brief Summary
-----------------
RATIONALE: Learning about the amount of information on fertility and infertility by patients before they received treatment for cancer in a comprehensive cancer center may help doctors plan the best treatment. PURPOSE: This clinical trial is studying the amount of information on fertility and infertility received by patients before treatment of cancer in patients who have finished treatment.

Detailed Description
-----------------
OBJECTIVES: Primary To determine the amount of information received on aspects of fertility and infertility in patients with cancer prior to receiving treatment in a comprehensive cancer center. Secondary To analyze whether the information received by patients is related to the desire to be parents. To analyze whether the information received by patients is related to the desire to be informed. To determine whether there is a relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received by patients. OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information received prior to therapy and psychosocial issues on aspects of fertility and infertility once within 1-2 years after receiving treatment.

Official Title
-----------------
Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center

Conditions
-----------------
Cancer

Intervention / Treatment
-----------------
* Other: questionnaire administration
* Other: study of socioeconomic and demographic variables
* Procedure: assessment of therapy complications
* Procedure: fertility assessment and management
* Procedure: psychosocial assessment and care
* Procedure: quality-of-life assessment


Participation Criteria
=================
Eligibility Criteria
-----------------
DISEASE CHARACTERISTICS: Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or sarcoma Free of disease Completed treatment within the past 1-2 years PATIENT CHARACTERISTICS: ECOG performance status 0-1 Must be able to read and self-complete study questionnaires No psychological conditions that may prevent participation in the study PRIOR CONCURRENT THERAPY: See Disease Characteristics No concurrent treatment (hormonal treatment for breast cancer is allowed)

Ages Eligible for Study
-----------------
Minimum Age: 18 Years
Maximum Age: 45 Years

Sexes Eligible for Study
-----------------
All

Accepts Healthy Volunteers
-----------------
No

Study Plan
=================
How is the study designed?
-----------------

Arms and Interventions

| Intervention/Treatment |
| --- |
|Other: questionnaire administration|nan|
|Other: study of socioeconomic and demographic variables|nan|
|Procedure: assessment of therapy complications|nan|
|Procedure: fertility assessment and management|nan|
|Procedure: psychosocial assessment and care|nan|
|Procedure: quality-of-life assessment|nan|

What is the study measuring?
-----------------
Primary Outcome Measures

| Outcome Measure | Measure Description | Time Frame |
| --- | --- | --- |
| Amount of information received on aspects of fertility and infertility |  |  | 
| Relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received |  |  | 

 Terms related to the study
=================
Keywords Provided by Centre Hospitalier Valida
-----------------
sexual dysfunction, psychosocial effects of cancer and its treatment, infertility, colon cancer, male breast cancer, breast cancer, germ cell tumor, ovarian sarcoma, uterine sarcoma, chronic lymphocytic leukemia, osteosarcoma, chronic myelogenous leukemia, non-Hodgkin lymphoma, adult acute myeloid leukemia with 11q23 (MLL) abnormalities, adult acute myeloid leukemia with inv(16)(p13;q22), adult acute myeloid leukemia with t(15;17)(q22;q12), adult acute myeloid leukemia with t(16;16)(p13;q22), adult acute myeloid leukemia with t(8;21)(q22;q22), mast cell leukemia, hairy cell leukemia, prolymphocytic leukemia, adult acute lymphoblastic leukemia, adult acute myeloid leukemia, adult Hodgkin lymphoma, adult T-cell leukemia/lymphoma, small intestine lymphoma, anaplastic large cell lymphoma, angioimmunoblastic T-cell lymphoma, mycosis fungoides/Sezary syndrome, intraocular lymphoma, primary central nervous system non-Hodgkin lymphoma, primary central nervous system Hodgkin lymphoma, noncutaneous extranodal lymphoma, secondary acute myeloid leukemia, acute undifferentiated leukemia, central nervous system leukemia, T-cell large granular lymphocyte leukemia, atypical chronic myeloid leukemia, BCR-ABL1 negative, clear cell sarcoma of the kidney, Kaposi sarcoma, adult soft tissue sarcoma, chronic myelomonocytic leukemia, secondary central nervous system Hodgkin lymphoma, cutaneous lymphoma, adult non-Hodgkin lymphoma